top of page
This site was designed with the
.com
website builder. Create your website today.Start Now
Dr Ifat Sher-Rosenthal_2 (3).tif

Dr. Ifat Sher is the Head of the Retinal Research Lab and a Senior Researcher at the Goldschleger Eye Institute, Sheba Medical Center, Tel Hashomer, Israel.

Dr. Sher received her PhD in Biology from the Technion-Israel Institute of Technology.

Following completion of a postdoctoral fellowship at Cornell University, New York, she joined the Sheba Medical Center where she studies neuroretinal degeneration and develops cell-based therapies for the treatment of retinal dystrophies. She is the Co-Founder and Chief Scientist of start-up companies and received several awards, including the Israeli Society of Vision and Eye Research, EMBO and Wolf foundation. 

Positions
Positions

2022-Present 

Goldschleger Eye Institute, Sheba Medical Center, Tel Hashomer, Israel.  Head of the Retinal Restoration Lab &  Senior Researcher 

2012-2021

Goldschleger Eye Institute, Sheba Medical Center, Tel Hashomer, Israel.  Researcher 

2017-2018

Everads Thearpy, Co-Founder and Chief Science Officer

2015-2017

Epitech Mag. Ltd., Co-Founder and Chief Science Officer
Education
Education

1996-1998

2008-2011

Cornell university, Research Associate Fellow​

2005-2007

University of Guelph, Post-doctoral Fellow​

1998-2004

Technion-Israel Institute of Technology, Ph.D. in Biology
Technion-Israel Institute of Technology, M.Sc. in Biology

1993-1996

Technion-Israel Institute of Technology, B.Sc. in Biology (Summa Cum Laude)
Awards & Fellowships
Awards & Felloships

2021 Sheba TLM Award for Distinguished Researchers

​

2014  Israeli Society of Vision and Eye Research Travel Award

​

2013  Shimon Rokah Award for distinguished young researcher

​

2005  Canadian Institutes of Health Research Fellowship Award for distinguished postdoctoral fellows 

​

2003 Technion scholarship for excellence; Graduate school

​

2002 Katzir Student Travel Fellowship for outstanding graduate students

​

2002-2004 Sandor Szego Excellence in Teaching Awards (each year)

​

2001   Wolf Foundation Scholarship for distinguished Ph.D. students

​

2000  EMBO Fellowship for outstanding graduate students

​

1997  Wolf Foundation Scholarship for distinguished M.Sc. students

​

1993-1996  President of the Technion Awards for outstanding B.Sc. students in each year

Publications
Recent Publications (last 4 years)

 

  1. Sher I, Tzameret A, Peri-Chen S, Edelshtain V, Ioffe M, Sayer A, Buzhansky L, Gazit E, Rotenstreich Y. Synthetic 9-cis-beta-carotene inhibits photoreceptor degeneration in cultures of eye cups from rpe65rd12 mouse model of retinoid cycle defect. Sci Rep. 2018 Apr 17;8(1):6130. 

  2. Haj Yahia S, Hamburg A, Sher I, Ben Ner D, Yassin S, Chibel R, Mimouni M,Derazne E, Belkin M, Rotenstreich Y. Effect of Stimulus Intensity and Visual Field Location on Rod- and Cone-Mediated Pupil Response to Focal Light Stimuli. Invest Ophthalmol Vis Sci. 2018 Dec 3;59(15):6027-6035.  

  3. Sher I, Tzameret A, Szalapak AM, Carmeli T, Derazne E, Avni-Zauberman N, Marcovich AL, Ben Simon G, Rotenstreich Y.  Multimodal Assessment of Corneal Erosions Using Optical Coherence Tomography and Automated Grading of Fluorescein Staining in a Rabbit Dry Eye Model. Transl Vis Sci Technol. 2019 Feb 28;8(1):27. 

  4. Edelshtain V, Peled A, Tzameret A, Pri-Chen S, Ziv H, Derazne E, Harats D, Greenberg R, Harari A, Shaish A, Sher I, Rotenstreich Y. Long-term treatment with 9-cis-β-carotene rich alga dunaliella bardawil ameliorates photoreceptor degeneration in a mouse model of retinoid cycle defect. Algal Research. 2019 Nov; 43:101607

  5. Tzameret A, Ketter-Katz H, Edelshtain V, Sher I, Corem-Salkmon E, Levy I, Last D, Guez D, Mardor Y, Margel S, Rotenstreich Y. In vivo MRI assessment of bioactive magnetic iron oxide/human serum albumin nanoparticle delivery into the posterior segment of the eye in a rat model of retinal degeneration. J Nanobiotechnology. 2019 Jan 10;17(1):3.

  6. Peled A, Afek A, Twig G, Pras E, Rotenstreich Y, Sher I, Derazne E, Tzur D, Gordon B. Myopia and Childhood Migration: A Study of 607 862 Adolescents. Ophthalmology. 2020 Jun;127(6):713-723.

  7. Sher I, Tzameret A, Goldberg Z, Bubis E, Avni-Zauberman N, Kalter-Leibovici O, Marcovich AL, Ben Simon G, Rotenstreich Y. Repetitive magnetic stimulation protects corneal epithelium in a rabbit model of short-term exposure keratopathy. Ocul Surf. 2020 Jan;18(1):64-73.

  8. Leshno A, Rubinstein Y, Singer R, Sher I, Rotenstreich Y, Melamed S, Skaat A. High-intensity Focused Ultrasound Treatment in Moderate Glaucoma Patients: Results of a 2-year Prospective Clinical Trial. J Glaucoma. 2020 Mar 24. 

  9. Sher I, Tucker Y, Gurevich M, Hamburg A, Bubis E, Kfir J, Zorani S, Derazne E, Skaat A, Rotenstreich Y. Chromatic pupilloperimetry measures correlate with visual acuity and visual field defects in retinitis pigmentosa patients. Transl Vis Sci Technol. Jul;9(8):10.

  10. Sher I, Bubis E, Ketter-Katz H, Goldberg Z, Saeed R, Rotenstreich Y. Efficacy and safety of injecting increasing volumes into the extravascular spaces of the choroid using a blunt adjustable depth injector. International Ophthalmology. 2020 Nov;40(11):2865-2874.

  11. Yehezkeli V, Rotenstreich Y, Haim LNB, Sher I, Achiron A, Belkin A. Ophthalmic emergency-room visits during the Covid-19 pandemic - a comparative study. BMC Ophthalmol. 2021 May 12;21(1):210

  12. Sher I, Goldberg Z, Bubis E, BarakY, Rotenstreich Y. Novel suprachoroidal delivery system for injection of high volumes and rapid distribution of bevacizumab throughout the choroid layers. European Journal of Pharmaceutics and Biopharmaceutics.  2021 Dec;169:200-210

bottom of page